SCHEMBL18653116

SCHEMBL18653116

O=NC(=O)/C=C/c1ccc(Br)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.51
▸ ESR2 Q92731 1/20 0.51
▸ HDAC1 Q13547 3/20 0.51
▸ HDAC3 O15379 2/20 0.50
▸ HDAC4 P56524 2/20 0.50
▸ HDAC2 Q92769 2/20 0.50
▸ HDAC10 Q969S8 2/20 0.50
▸ HDAC6 Q9UBN7 2/20 0.50
▸ HDAC5 Q9UQL6 2/20 0.50
▸ CYP1B1 Q16678 2/20 0.49
▸ SLC5A1 P13866 1/20 0.49
▸ SLC5A2 P31639 1/20 0.49
▸ MAPT P10636 5/20 0.47
▸ LMNA P02545 3/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ POLB P06746 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16381772 0.82 TYR (0.63) ESR1ESR2HDAC1HDAC3HDAC4
SCHEMBL15943011 0.82 HCAR2 (0.61) ESR1ESR2HDAC1HDAC3HDAC4
SCHEMBL15483131 0.80 HDAC1 (0.54) ESR1ESR2HDAC1HDAC3HDAC4
SCHEMBL22882015 0.80 HDAC1 (0.51) ESR1ESR2HDAC1HDAC3HDAC4
SCHEMBL5426867 0.79 HTR2B (0.48) ESR1ESR2CYP1B1SLC5A1SLC5A2
SCHEMBL16588259 0.79 HDAC1 (0.61) HDAC1HDAC3HDAC4HDAC2HDAC10
SCHEMBL1375665 0.79 F3 (0.64) ESR1ESR2CYP1B1SLC5A1SLC5A2
SCHEMBL2744670 0.79 F3 (0.64) ESR1ESR2CYP1B1SLC5A1SLC5A2
SCHEMBL13460135 0.78 ESR1 (0.46) ESR1ESR2CYP1B1SLC5A1SLC5A2
SCHEMBL28735628 0.78 ESR1 (0.46) ESR1ESR2CYP1B1SLC5A1SLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678334-B1 ANTI-VIRAL COMPOUNDS ABBVIE BAHAMAS LTD (BS) 2017-03-22 — — EP disclosed
Send feedback